Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis-Reference-Cited by-同舟云学术

Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis

Published:2018-10-01 Issue:12 Volume:84 Page:2849-2856
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Green Jordan R.¹²,Allison Kristen M.¹³,Cordella Claire¹²,Richburg Brian D.¹^ORCID,Pattee Gary L.⁴,Berry James D.⁵,Macklin Eric A.⁶⁷,Pioro Erik P.⁸,Smith Richard A.⁹

Affiliation:

1. Speech and Feeding Disorders Lab; MGH Institute of Health Professions; Charlestown MA USA

2. Program in Speech and Hearing Bioscience and Technology Program, Division of Medical Sciences; Harvard University; Boston MA USA

3. Department of Communication Sciences and Disorders, Bouve College of Health Sciences; Northeastern University; Boston MA USA

4. Department of Neurology; University of Nebraska Medical College; Omaha NE USA

5. Department of Neurology; Massachusetts General Hospital; Boston MA USA

6. Biostatistics Center; Massachusetts General Hospital; Boston MA USA

7. Department of Medicine; Harvard Medical School; Boston MA USA

8. Department of Neurology; Cleveland Clinic Neuromuscular Center; Cleveland OH USA

9. Center for Neurologic Study; La Jolla CA USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13745/fullpdf

Reference38 articles.

1. A 24-week, phase III, double-blind, parallel-group study of edaravone (MCI-186) for treatment of amyotrophic lateral sclerosis (ALS)(P3. 189);Tanaka;Neurology,2016

2. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group;Bensimon;N Engl J Med,1994

3. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis;Ferraiuolo;Nat Rev Neurol,2011

4. Riluzole, neuroprotection and amyotrophic lateral sclerosis;Cheah;Curr Med Chem,2010

5. Enhanced bulbar function in amyotrophic lateral sclerosis: the Nuedexta treatment trial;Smith;Neurotherapeutics,2017

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Speech timing and monosyllabic diadochokinesis measures in the assessment of amyotrophic lateral sclerosis in Canadian French;International Journal of Speech-Language Pathology;2023-06-05

2. Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis;Annals of Clinical and Translational Neurology;2023-06-02

3. Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders;CNS Drugs;2023-05

4. Immunization with Neural-Derived Peptides in Neurodegenerative Diseases: A Narrative Review;Biomedicines;2023-03-16

5. Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures;npj Digital Medicine;2023-03-06